💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

Rhythm Pharmaceuticals Inc (1RV)

Frankfurt
Currency in EUR
Disclaimer
48.8000
0.0000(0.00%)
Closed
1RV Scorecard
Full Analysis
Impressive gross profit margins
Trading near 52-week High
Fair Value
Day's Range
48.000048.8000
52 wk Range
19.800048.8000
Bid/Ask
48.60 / 49.20
Prev. Close
48.8
Open
48
Day's Range
48-48.8
52 wk Range
19.8-48.8
Volume
1
Average Volume (3m)
8
1-Year Change
114.04%
Fair Value
Unlock
Fair Value Upside
Unlock
1RV Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
59.3000
Upside
+8.7076%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory
Show more

Rhythm Pharmaceuticals Inc Company Profile

Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases. The company’s lead product candidate is IMCIVREE (setmelanotide), a rare melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström syndrome. It is in Phase 3 clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 deficiency obesity, MC4 receptor deficiency obesity, and other MC4R disorders. The company has licensing agreements with LG Chem, Ltd; Ipsen Pharma S.A.S; Camurus; RareStone Group Ltd.; and LG Chem, Ltd. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. Rhythm Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Compare 1RV to Peers and Sector

Metrics to compare
1RV
Peers
Sector
Relationship
P/E Ratio
−12.6x−2.7x−0.6x
PEG Ratio
0.38−0.060.00
Price/Book
83.3x2.5x2.6x
Price / LTM Sales
32.2x14.6x3.1x
Upside (Analyst Target)
-248.9%56.7%
Fair Value Upside
Unlock22.8%7.8%Unlock

FAQ

What Is the Rhythm Pharma (1RV) Stock Price Today?

The Rhythm Pharma stock price today is 48.80.

What Stock Exchange Does Rhythm Pharma Trade On?

Rhythm Pharma is listed and trades on the Frankfurt stock exchange.

What Is the Stock Symbol for Rhythm Pharma?

The stock symbol for Rhythm Pharma is "1RV."

What Is the Rhythm Pharma Market Cap?

As of today, Rhythm Pharma market cap is 2.94B.

What is Rhythm Pharma Earnings Per Share?

The Rhythm Pharma EPS is -4.38.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.